Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine PRP versus G-CSF in repeated implantation failure
IRCT20180528039878N3Phase 3Completed
- Sponsor
- Mehr Medical Institute
- Start
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of platelet-rich plasma and granulocyte colony-stimulating factor in Recurrent Implantation Failure (RIF) (2 arms), sponsored by Mehr Medical Institute. Primary endpoints: Clinical pregnancy and Ongoing pregnancy. Started Jul 2021; status: completed.
02
Drugs
platelet-rich plasmagranulocyte colony-stimulating factor
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20180528039878N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180528039878N3.